MetaCap

4D Molecular Therapeutics Insider Trades

NASDAQ: FDMTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

13.33+0.63 (+4.96%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
2 · $753.94K
Shares bought / sold
0 / 58.33K
Net activity
Net selling $753,937

4D Molecular Therapeutics insider activity

Over the last 12 months, 4D Molecular Therapeutics insiders reported 2 transactions on SEC Form 4: 0 open-market purchases and 2 sales. Insiders bought $0 and sold $753,937 worth of stock, for net insider selling of $753,937. The largest seller was Kirn David, with $753,937 in reported sales.

The most recent filing shows Kirn David (See Remarks) selling 58,061 shares at $12.92 on Oct 5, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put FDMT's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

FDMT insider transactions

4D Molecular Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Oct 5, 2026Kirn DavidSee RemarksSale272$3.70KForm 4
Oct 5, 2026Kirn DavidSee RemarksSale58,061$750.24KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related